Cryoglobulinemia - of the fingers
Cryoglobulinemia - of the fingers
Immune system structures
Immune system structures
Antibodies
Antibodies

Multiple myeloma

Definition:
Multiple myeloma is a cancer of the plasma cells in bone marrow.

Alternative Names:
Plasma cell dyscrasia; Plasma cell myeloma; Malignant plasmacytoma; Plasmacytoma of bone

Causes, incidence, and risk factors:

Multiple myeloma is characterized by the excessive growth and malfunction of plasma cells in the bone marrow. The growth of these extra plasma cells interferes with the production of red blood cells, white blood cells, and platelets. This causes anemia, susceptibility to infection, and increased tendencies toward bleeding.

As the cancer cells grow and expand in the bone marrow, they also cause pain and destruction of the bones. If the bones in the spine are affected, compression of the nerves may result causing numbness or paralysis.

Renal failure (kidney failure) is a frequent complication caused by excess calcium in the blood that results from bone destruction. Multiple myeloma mainly affects older adults. Other risk factors are unknown. This disease is rare and only 3 new cases per 100,000 people per year occur.

Symptoms:
Signs and tests:
This disease may also alter the results of the following tests:
Treatment:

The goal of treatment is to relieve symptoms, since chemotherapy and even transplant rarely lead to permanent cure. Complete remission is unusual.

People who have mild disease or in whom the diagnosis is in doubt are usually observed without treatment. Some people have a slow-developing form which takes years before it causes symptoms. When the disease advances or causes symptoms, treatment is begun.

Chemotherapy and localized radiation therapy for relief of bone pain or treating a bone tumor may be useful. Bone marrow transplantation in younger patients is sometimes used, but the long-term results of this treatment are not known.

There are many medical studies (clinical trials) to look for better ways to treat multiple myeloma and some promising new treatments being tested, so you should discuss participation with your doctor.

Symptoms of high serum calcium levels are treated, and dehydration is avoided to help maintain proper kidney function.

Support Groups:
The stress of illness can often be helped by joining a support group where members share common experiences and problems. See cancer - support group.
Expectations (prognosis):
The average (median) survival of people with multiple myeloma is about 3 years, but this depends on the patient's age and the stage of disease. Some cases are very aggressive, while others take years to progress -- so discuss your individual condition with your doctor.
Complications:
Calling your health care provider:
Call your health care provider if you experience decreased urine output.

Call your health care provider if you have multiple myeloma and infection develops, or numbness, loss of movement, or loss of sensation develops.

Review Date: 8/23/2002
Reviewed By: Scott Howard, M.D., M.S., Memphis, TN. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.